Long-term Impact of Universal Treatment and Dolutegravir on Population HIV Virologic and incidence outcomes in Africa (Long-term view Study)

The Longview Study, nested within the Rakai Community Cohort Study in Uganda, is a population-level, prospective assessment of viral load suppression, HIV drug resistance, and incidence before and after COVID-19, involving ~20,000 participants across 40 communities with high HIV prevalence and drug resistance, spanning multiple surveys from 2013 to 2025.  

Join us in our mission to advance health research and improve public health outcomes globally.

Collaborate for Health, Innovate for Impact.